Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2008

Physical activity assessed with three different methods and the Framingham Risk Score on 10-year coronary heart disease risk

Richard R SuminskiACDEF, Walker S.C. PostonADE, John P. ForeytBCDG, Sachiko St. JeorBCDG

Med Sci Monit 2008; 14(1): CR1-9 :: ID: 636047

Abstract

Background
Physical activity (PA) protects against coronary heart disease (CHD) by favorably altering several CHD risk factors. In order to best understand the true nature of the relationship between PA and CHD, the impact different PA assessment methods have on the relationships must first be clarified. The purpose of this study was to examine associations between the Framingham Risk Score on 10-year estimated risk of CHD (10-year CHD risk) and three different PA assessment methods.
Material and Method
Female (n=143) and male (n=155) adults wore activity monitors and recorded PA in logs during a seven-day period after which they completed a seven-day PA recall and had CHD risk factors assessed. The 10-year CHD risk was calculated from the CHD risk factors.
Results
Multiple regression analyses showed 10-year CHD risk was negatively associated with physical activity measured by the activity monitor (p<0.05) but not the log or recall in women. In men, significant inverse relationships between 10-year CHD risk and physical activity measured by the activity monitor and recall were observed. The log was not significantly associated with 10-year CHD risk in men.
Conclusions
The results of this study concur with previous research in that PA is associated with the risk of developing CHD; however, the findings clearly suggest that it is important to consider the PA assessment method when interpreting this relationship.

Keywords: Regression Analysis, Motor Activity - physiology, Massachusetts, Lipids - blood, Energy Intake, Coronary Disease - prevention & control, Time Factors, Risk Factors, Body Mass Index, Blood Pressure, Alcohol Drinking

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750